| Ytd | -28.80% | |
| 1y | -61.30% |
| Open | 0.93 | Prev Close | 0.92 | Low | 0.88 | High | 0.93 | Mkt Cap | 5.35M |
| Vol | 96.11K | Avg Vol | 3.13M | EPS | -0.91 | P/E | -1.01 | Forward P/E | -1.57 |
| Beta | 0.44 | Short Ratio | 1.41 | Inst. Own | 2.21% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 0.97 | 200-d Avg | 1.20 | 1yr Est | 25.00 |
BCDA News
Gainers Ernexa Therapeutics (NASDAQ:ERNA) stock increased by 88.3% to $11.41 during Wednesday's
Gainers Exicure (NASDAQ:XCUR) stock rose 38.4% to $2.38 during Tuesday's after-market session.
AZ, AISP and BCDA have been added to the Zacks Rank #5 (Strong Sell) List on July 14th, 2026.
SUNNYVALE, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a global leade
Net proceeds anticipated to extend cash runway into first quarter of 2027 beyond expected Japan PMDA
BioCardia Inc. (NASDAQ:BCDA) stock is up on Friday as the company is confirming progress toward pote
SUNNYVALE, Calif., June 05, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a global leade
– Positive CardiAMP CMI Trial open-label cohort results demonstrated opportunity for locally deliver
BioCardia, Inc. (BCDA) Q1 2026 Earnings Call Transcript
SUNNYVALE, Calif., May 15, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader
SUNNYVALE, Calif. , May 11, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [NASDAQ: BCDA], a developer of
SUNNYVALE, Calif. , May 08, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader
SUNNYVALE, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a global lead
NEW YORK--(BUSINESS WIRE)--Tamboran Resources Corporation (NYSE: TBN, ASX: TBN): Tamboran Resources
BioCardia (NASDAQ: BCDA) executives on Tuesday outlined new clinical data for the company's lead cel
BioCardia, Inc. (BCDA) Q4 2025 Earnings Call Transcript
SUNNYVALE, Calif., March 24, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leade
SUNNYVALE, Calif., March 19, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of
Shares of BioCardia, Inc. (NASDAQ: BCDA - Get Free Report) fell 3.9% on Wednesday. The company trade
SUNNYVALE, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of
SUNNYVALE, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ: BCDA], a developer of
Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCo
Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earn
Gainers
Stocks That Hit 52-Week Lows On Wednesday